Heart1.com: Great Information, Real Community, Better Living.
 Register
 Login
 Main Page
 Heart News
Feature Story
 Education Center
Conditions
Procedures
Diagnostics
 Heart Attack Center
Prevention
Survivors
Dr. Tod Engelhardt  Heart
 Hero™

Dr. Tod Engelhardt:
Combating Major Blood Clots.
About Heroes
 Join the Discussion  in  Our Forums
 Community
Heart1 Forums
Patient Stories
 Reference
Online Resources
Video Library
advertisement
Search the Body1 Network
March 26, 2019  
HEART NEWS: Feature Story

  • Print this Article
  • Email this Article
  • Links/Reprints
  • Clots Prompt Warning to Properly Use New Stents

    Clots Prompt Warning to Properly Use New Stents


    July 08, 2003

    WASHINGTON (AP) - Doctors got a stern warning Tuesday to properly use a popular new drug-coated heart stent that has been linked to blood clots in almost three dozen people, including five who died.

    The Cypher stent is a tiny metal scaffold that props open a cleaned-out artery and, unlike other stents, emits a drug to reduce the chances the artery will clog again.

    But the drug doesn't prevent a different risk posed by all stents - blood clots that form around the device and can cause a heart attack.

    The Food and Drug Administration has received reports of blood clots in 34 Cypher stent recipients. Five of those patients died, although FDA doesn't know if the clots actually caused the deaths, a spokeswoman said.

    In a letter to more than 1,200 cardiac centers, manufacturer Cordis Corp. called the risk very rare considering 50,000 patients have received a Cypher stent since the eagerly awaited device began selling in April.

    But Cordis cautioned that some of the clots happened after doctors improperly used the Cypher by choosing stents that were too small, implanting them improperly or not giving patients appropriate anti-clotting medicine afterward.

    The Food and Drug Administration echoed that warning Tuesday.

    In studies where Cypher was implanted under strict conditions, it proved no more likely to cause blood clots than long-used bare-metal stents, the FDA said.

    It's not yet clear if clots among Cypher patients are occurring more often today than in those studies, said FDA cardiovascular devices chief Dr. Bram Zuckerman. He said clearly some physicians are incorrectly using the Cypher and should heed the following safe-use guidelines:

    -Cypher stents are only for new patients, not to replace a reclogged stent.

    -Recipients must take anti-clotting drugs for three months after getting the stent - not the mere two weeks prescribed for bare-metal stents - because arteries heal slower after Cypher insertion.

    -Closely match stent size to artery diameter. Demand for the Cypher greatly eclipsed supply when it debuted, and Cordis said it initially concentrated on making smaller sizes but now offers a larger size.

    -Be sure the stent is fully open, touching the artery wall.

    Cordis will begin an FDA-ordered registry this month to further track Cypher outcomes. Meanwhile, doctors should report any side effects to Cordis at 1-800-327-7714, or to FDA at 1-800-FDA-1088 or http://www.fda.gov/MedWatch.


    Last updated: 08-Jul-03

    Comments

  • Add Comment
  •    
    Interact on Heart1

    Discuss this topic with others.
     
    Feature Archives

    Heart Disease Patients Need to Exercise to Benefit from the Protective Effects of Wine

    Effective Treatment for Heart Failure Possible Following Discovery of Heart Molecule

    Significant Decrease in Heart Disease after Prison Smoking Bans

    Heart Failure Patients Who Sleep Poorly Are at Double the Risk for Hospitalization

    Long-Term Survival Possible for Pediatric Heart Transplant Patients

    Next 5 Features ...

    More Features ...
       
     
    Related Multimedia

    The risk of cardiac death due to a lower ejection fraction

    The function of a defibrillator

    Plaques/fatty deposits as a cause for a heart attack

    More Features ...
     
    Related Content
    J&J, Guidant to Co-Promote Heart Stents

    New Drug-Coated Stents Exceeds Supply

    Court Upholds Denial of Stent Injunction

    FDA Panel Cautiously Backs New Stent

    Boston Scientific Presents Results from TAXUS Stent Trials at TCT

    More Features ...
     
    Home About Us Press Jobs Advertise With Us Contact Us
    advertisement
    © 2019 Body1 All rights reserved.
    Disclaimer: The information provided within this website is for educational purposes only and is not a substitute for consultation with your physician or healthcare provider. The opinions expressed herein are not necessarily those of the Owners and Sponsors of this site. By using this site you agree to indemnify, and hold the Owners and Sponsors harmless, from any disputes arising from content posted here-in.